Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 41

1.

Pneumocystis primary infection in infancy: Additional French data and review of the literature.

Nevez G, Guillaud-Saumur T, Cros P, Papon N, Vallet S, Quinio D, Minoui-Tran A, Pilorgé L, de Parscau L, Sizun J, Ochoa TJ, Bustamante B, Ponce C, Vargas SL, Le Gal S.

Med Mycol. 2019 May 25. pii: myz040. doi: 10.1093/mmy/myz040. [Epub ahead of print]

PMID:
31127850
2.

[Invasive Fusariosis: Report of Three Cases in Peru].

Maquera-Afaray J, Pérez-Lazo G, Rodriguez R, Illescas R, Rodriguez L, Hidalgo J, Bustamante B, Herrera C, Díaz A.

Rev Peru Med Exp Salud Publica. 2018 Jul-Sep;35(3):523-526. doi: 10.17843/rpmesp.2018.353.3175. Spanish.

3.

Can the post-error effect mask age-related differences in congruency conditions when education and overall accuracy are controlled for?

Pereiro AX, Bustamante BF, Cisneros MA, Juncos-Rabadán O.

Acta Psychol (Amst). 2018 Jul;188:177-187. doi: 10.1016/j.actpsy.2018.06.008. Epub 2018 Jun 26.

PMID:
29958122
4.

Posaconazole MIC Distributions for Aspergillus fumigatus Species Complex by Four Methods: Impact of cyp51A Mutations on Estimation of Epidemiological Cutoff Values.

Espinel-Ingroff A, Turnidge J, Alastruey-Izquierdo A, Dannaoui E, Garcia-Effron G, Guinea J, Kidd S, Pelaez T, Sanguinetti M, Meletiadis J, Botterel F, Bustamante B, Chen YC, Chakrabarti A, Chowdhary A, Chryssanthou E, Córdoba S, Gonzalez GM, Guarro J, Johnson EM, Kus JV, Lass-Flörl C, Linares-Sicilia MJ, Martín-Mazuelos E, Negri CE, Pfaller MA, Tortorano AM.

Antimicrob Agents Chemother. 2018 Mar 27;62(4). pii: e01916-17. doi: 10.1128/AAC.01916-17. Print 2018 Apr.

5.

Bedside diagnostics in dermatology: Viral, bacterial, and fungal infections.

Wanat KA, Dominguez AR, Carter Z, Legua P, Bustamante B, Micheletti RG.

J Am Acad Dermatol. 2017 Aug;77(2):197-218. doi: 10.1016/j.jaad.2016.06.034. Review.

PMID:
28711082
6.

Mental Health Problems and Related Factors in Ecuadorian College Students.

Torres C, Otero P, Bustamante B, Blanco V, Díaz O, Vázquez FL.

Int J Environ Res Public Health. 2017 May 15;14(5). pii: E530. doi: 10.3390/ijerph14050530.

7.

A multi-centric Study of Candida bloodstream infection in Lima-Callao, Peru: Species distribution, antifungal resistance and clinical outcomes.

Rodriguez L, Bustamante B, Huaroto L, Agurto C, Illescas R, Ramirez R, Diaz A, Hidalgo J.

PLoS One. 2017 Apr 18;12(4):e0175172. doi: 10.1371/journal.pone.0175172. eCollection 2017.

8.

Factors associated with early mycological clearance in HIV-associated cryptococcal meningitis.

Concha-Velasco F, González-Lagos E, Seas C, Bustamante B.

PLoS One. 2017 Mar 29;12(3):e0174459. doi: 10.1371/journal.pone.0174459. eCollection 2017.

9.

Serious fungal infections in Peru.

Bustamante B, Denning DW, Campos PE.

Eur J Clin Microbiol Infect Dis. 2017 Jun;36(6):943-948. doi: 10.1007/s10096-017-2924-9. Epub 2017 Feb 10.

PMID:
28188491
10.

[Epidemiological clinical and laboratory characterization of sporotrichosis in patients of a tertiary care hospital in Lima, Peru, from 1991 to 2014].

Oyarce JA, García C, Alave J, Bustamante B.

Rev Chilena Infectol. 2016 Jun;33(3):315-21. doi: 10.4067/S0716-10182016000300012. Spanish.

11.

Phaeoacremonium sphinctrophorum as a Novel Agent of Eumycetoma.

Bustamante B, Ahmed SA, De Hoog GS, Seas C, Van De Sande WW.

JAMA Dermatol. 2016 Sep 1;152(9):1063-5. doi: 10.1001/jamadermatol.2016.1310. No abstract available.

PMID:
27224667
12.

Species distribution and antifungal susceptibility profile of Candida isolates from bloodstream infections in Lima, Peru.

Bustamante B, Martins MA, Bonfietti LX, Szeszs MW, Jacobs J, Garcia C, Melhem MS.

J Med Microbiol. 2014 Jun;63(Pt 6):855-60. doi: 10.1099/jmm.0.071167-0. Epub 2014 Mar 25.

PMID:
24667770
13.

Multilaboratory study of epidemiological cutoff values for detection of resistance in eight Candida species to fluconazole, posaconazole, and voriconazole.

Espinel-Ingroff A, Pfaller MA, Bustamante B, Canton E, Fothergill A, Fuller J, Gonzalez GM, Lass-Flörl C, Lockhart SR, Martin-Mazuelos E, Meis JF, Melhem MS, Ostrosky-Zeichner L, Pelaez T, Szeszs MW, St-Germain G, Bonfietti LX, Guarro J, Turnidge J.

Antimicrob Agents Chemother. 2014;58(4):2006-12. doi: 10.1128/AAC.02615-13. Epub 2014 Jan 13.

14.

Multicenter study of anidulafungin and micafungin MIC distributions and epidemiological cutoff values for eight Candida species and the CLSI M27-A3 broth microdilution method.

Pfaller MA, Espinel-Ingroff A, Bustamante B, Canton E, Diekema DJ, Fothergill A, Fuller J, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SR, Martin-Mazuelos E, Meis JF, Ostrosky-Zeichner L, Pelaez T, St-Germain G, Turnidge J.

Antimicrob Agents Chemother. 2014;58(2):916-22. doi: 10.1128/AAC.02020-13. Epub 2013 Nov 25.

15.

Interlaboratory variability of Caspofungin MICs for Candida spp. Using CLSI and EUCAST methods: should the clinical laboratory be testing this agent?

Espinel-Ingroff A, Arendrup MC, Pfaller MA, Bonfietti LX, Bustamante B, Canton E, Chryssanthou E, Cuenca-Estrella M, Dannaoui E, Fothergill A, Fuller J, Gaustad P, Gonzalez GM, Guarro J, Lass-Flörl C, Lockhart SR, Meis JF, Moore CB, Ostrosky-Zeichner L, Pelaez T, Pukinskas SR, St-Germain G, Szeszs MW, Turnidge J.

Antimicrob Agents Chemother. 2013 Dec;57(12):5836-42. doi: 10.1128/AAC.01519-13. Epub 2013 Sep 9.

16.

Can trained dogs detect a hypoglycemic scent in patients with type 1 diabetes?

Dehlinger K, Tarnowski K, House JL, Los E, Hanavan K, Bustamante B, Ahmann AJ, Ward WK.

Diabetes Care. 2013 Jul;36(7):e98-9. doi: 10.2337/dc12-2342. No abstract available.

17.

Lobomycosis successfully treated with posaconazole.

Bustamante B, Seas C, Salomon M, Bravo F.

Am J Trop Med Hyg. 2013 Jun;88(6):1207-8. doi: 10.4269/ajtmh.12-0428. Epub 2013 Apr 1.

18.

A probable association between HTLV-1 and endemic mycosis in Latin America.

Leon M, Alave J, Bustamante B, Gotuzzo E, Seas C.

J Infect Dev Ctries. 2012 Mar 12;6(3):301. No abstract available.

19.

Correlation of susceptibility of Cryptococcus neoformans to amphotericin B with clinical outcome.

Larsen RA, Bauer M, Pitisuttithum P, Sanchez A, Tansuphaswadikul S, Wuthiekanun V, Peacock SJ, Simpson AJ, Fothergill AW, Rinaldi MG, Bustamante B, Thomas AM, Altomstone R, Day NP, White NJ.

Antimicrob Agents Chemother. 2011 Dec;55(12):5624-30. doi: 10.1128/AAC.00034-11. Epub 2011 Sep 26.

20.

Acalculous Cholecystitis caused by Histoplasma capsulatum in a severely immunosuppressed HIV-infected patient.

Alave J, Bustamante B, Soto L, Caceres J, Seas C.

J Infect Dev Ctries. 2011 Mar 21;5(3):235-8.

21.

Symptomatic duodenal cryptococcosis in HIV-infected individuals.

León M, Alave J, Martinez D, Bustamante B, Rodriguez M, Seas C.

Med Mycol. 2011 Oct;49(7):775-8. doi: 10.3109/13693786.2011.563325. Epub 2011 Feb 28.

PMID:
21355712
22.

A 13-year-old boy with ataxia 4 weeks after a near-drowning accident.

León M, Alave J, Chaparro E, Bustamante B, Seas C.

Clin Infect Dis. 2010 Aug 1;51(3):326-7, 363-4. doi: 10.1086/653941. No abstract available.

PMID:
20597680
23.

Human T lymphotropic virus 1 and paracoccidioidomycosis: a probable association in Latin America.

León M, Alave J, Bustamante B, Cok J, Gotuzzo E, Seas C.

Clin Infect Dis. 2010 Jul 15;51(2):250-1. doi: 10.1086/653679. No abstract available.

PMID:
20560735
24.

Treatment of cryptococcal meningitis in Peruvian AIDS patients using amphotericin B and fluconazole.

Dammert P, Bustamante B, Ticona E, Llanos-Cuentas A, Huaroto L, Chávez VM, Campos PE.

J Infect. 2008 Sep;57(3):260-5. doi: 10.1016/j.jinf.2008.06.020. Epub 2008 Aug 15.

PMID:
18707764
25.

Clinical practice guidelines for the management of sporotrichosis: 2007 update by the Infectious Diseases Society of America.

Kauffman CA, Bustamante B, Chapman SW, Pappas PG; Infectious Diseases Society of America.

Clin Infect Dis. 2007 Nov 15;45(10):1255-65. Epub 2007 Oct 8.

PMID:
17968818
26.

Evaluation of cats as the source of endemic sporotrichosis in Peru.

Kovarik CL, Neyra E, Bustamante B.

Med Mycol. 2008 Feb;46(1):53-6.

PMID:
17885948
27.

Posaconazole treatment of refractory eumycetoma and chromoblastomycosis.

Negroni R, Tobón A, Bustamante B, Shikanai-Yasuda MA, Patino H, Restrepo A.

Rev Inst Med Trop Sao Paulo. 2005 Nov-Dec;47(6):339-46.

PMID:
16553324
28.

Larvicidal, antimycobacterial and antifungal compounds from the bark of the Peruvian plant Swartzia polyphylla DC.

Rojas R, Bustamante B, Ventosilla P, Fernádez I, Caviedes L, Gilman RH, Lock O, Hammond GB.

Chem Pharm Bull (Tokyo). 2006 Feb;54(2):278-9.

29.

Activity of posaconazole in the treatment of central nervous system fungal infections.

Pitisuttithum P, Negroni R, Graybill JR, Bustamante B, Pappas P, Chapman S, Hare RS, Hardalo CJ.

J Antimicrob Chemother. 2005 Oct;56(4):745-55. Epub 2005 Aug 31.

PMID:
16135526
30.

Epidemiology of human sporotrichosis investigated by amplified fragment length polymorphism.

Neyra E, Fonteyne PA, Swinne D, Fauche F, Bustamante B, Nolard N.

J Clin Microbiol. 2005 Mar;43(3):1348-52.

31.

Antimicrobial and free radical scavenging activity of Gentianella nitida.

Rojas R, Doroteo V, Bustamante B, Bauer J, Lock O.

Fitoterapia. 2004 Dec;75(7-8):754-7.

PMID:
15567257
32.

Sporotrichosis: a forgotten disease in the drug research agenda.

Bustamante B, Campos PE.

Expert Rev Anti Infect Ther. 2004 Feb;2(1):85-94. Review.

PMID:
15482174
33.

Recombinant interferon- gamma 1b as adjunctive therapy for AIDS-related acute cryptococcal meningitis.

Pappas PG, Bustamante B, Ticona E, Hamill RJ, Johnson PC, Reboli A, Aberg J, Hasbun R, Hsu HH.

J Infect Dis. 2004 Jun 15;189(12):2185-91. Epub 2004 May 24.

PMID:
15181565
34.

Antimicrobial activity of selected Peruvian medicinal plants.

Rojas R, Bustamante B, Bauer J, Fernández I, Albán J, Lock O.

J Ethnopharmacol. 2003 Oct;88(2-3):199-204.

PMID:
12963143
35.

Species distribution and antifungal susceptibility profile of Candida spp. bloodstream isolates from Latin American hospitals.

Godoy P, Tiraboschi IN, Severo LC, Bustamante B, Calvo B, Almeida LP, da Matta DA, Colombo AL.

Mem Inst Oswaldo Cruz. 2003 Apr;98(3):401-5. Epub 2003 Jul 18.

36.

Endemic sporotrichosis.

Bustamante B, Campos PE.

Curr Opin Infect Dis. 2001 Apr;14(2):145-9. Review.

PMID:
11979124
37.

Sporotrichosis in Peru: description of an area of hyperendemicity.

Pappas PG, Tellez I, Deep AE, Nolasco D, Holgado W, Bustamante B.

Clin Infect Dis. 2000 Jan;30(1):65-70.

PMID:
10619735
38.

Comparison of terbinafine and griseofulvin in the treatment of tinea capitis.

Cáceres-Ríos H, Rueda M, Ballona R, Bustamante B.

J Am Acad Dermatol. 2000 Jan;42(1 Pt 1):80-4.

PMID:
10607324
39.

Treatment of cutaneous sporotrichosis with one daily dose of potassium iodide.

Cabezas C, Bustamante B, Holgado W, Begue RE.

Pediatr Infect Dis J. 1996 Apr;15(4):352-4.

PMID:
8866807
40.

Parotid saliva cortisol in normal subjects: increase during pregnancy.

Bustamante B, Crabbé J.

J Steroid Biochem. 1984 Jun;20(6A):133-6.

PMID:
6748648
41.

[Treatment of acute male gonococcal urethritis with a single dose of spectinomycin].

Martini J, Halabi J, Bustamante B, Borgoño JM.

Rev Med Chil. 1972 Jan;100(1):18-20. Spanish. No abstract available.

PMID:
4258909

Supplemental Content

Loading ...
Support Center